ZNQ:CA:TSX-BMO NASDAQ 100 Equity Index ETF (CAD)

ETF | US Equity |

Last Closing

CAD 87.95

Change

+1.16 (+1.34)%

Market Cap

CAD 0.94B

Volume

2.73K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+1.40 (+1.02%)

CAD 17.23B
ZSP:CA BMO S&P 500

+0.85 (+1.01%)

CAD 16.16B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.52 (+0.87%)

CAD 10.90B
VUN:CA Vanguard US Total Market

+1.11 (+1.08%)

CAD 9.56B
XUS:CA iShares Core S&P 500 Index ETF

+0.48 (+1.00%)

CAD 7.36B
HXS:CA Global X S&P 500 Corporate Cla..

+0.78 (+0.99%)

CAD 4.06B
VSP:CA Vanguard S&P 500 CAD hedged

+0.81 (+0.88%)

CAD 3.52B
QUU:CA Mackenzie US Large Cap Equity ..

+2.53 (+1.14%)

CAD 3.25B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.60 (+1.20%)

CAD 3.07B
XUU:CA iShares Core S&P US Total Mark..

+0.62 (+1.09%)

CAD 3.07B

ETFs Containing ZNQ:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.07% 72% C 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.07% 69% C- 77% C+
Trailing 12 Months  
Capital Gain 32.63% 84% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.63% 64% D 76% C+
Trailing 5 Years  
Capital Gain 163.17% 100% F 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 163.17% 100% F 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 20.32% N/A N/A 86% B+
Dividend Return 20.35% N/A N/A 85% B
Total Return 0.03% N/A N/A 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 22.50% N/A N/A 66% D+
Risk Adjusted Return 90.48% N/A N/A 94% A
Market Capitalization 0.94B 65% D 68% D+

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.